Virtu Financial LLC Acquires New Holdings in Senti Biosciences, Inc. (NASDAQ:SNTI)

Virtu Financial LLC bought a new position in shares of Senti Biosciences, Inc. (NASDAQ:SNTI) during the fourth quarter, Holdings Channel reports. The fund bought 13,356 shares of the company’s stock, valued at approximately $47,000.

Senti Biosciences Trading Down 3.6 %

SNTI stock opened at $3.24 on Wednesday. The company’s 50 day moving average is $3.83 and its 200 day moving average is $3.48. The stock has a market cap of $84.25 million, a price-to-earnings ratio of -0.21 and a beta of 2.52. Senti Biosciences, Inc. has a 1-year low of $1.52 and a 1-year high of $16.94.

Senti Biosciences (NASDAQ:SNTI) last posted its quarterly earnings results on Thursday, March 20th. The company reported ($0.67) EPS for the quarter, topping the consensus estimate of ($3.13) by $2.46. The business had revenue of $5.86 million for the quarter, compared to analysts’ expectations of $2.80 million. As a group, sell-side analysts forecast that Senti Biosciences, Inc. will post -14.54 EPS for the current fiscal year.

About Senti Biosciences

Senti Biosciences, Inc operates as a preclinical biotechnology company that develops next-generation cell and gene therapies engineered with its gene circuit platform technologies for various diseases. Its lead product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications.